Schistosome infection aggravates HCV-related liver disease and induces changes in the regulatory T-cell phenotype

Parasite Immunology

Volumn 37, Issue 2, 2015, Pages 97-104

  Loffredo Verde, E ^a   Abdel Aziz, I ^b   Albrecht, J ^a   El Guindy, N ^c   Yacob, M ^c   Solieman, A ^c   Protzer, U ^a   Busch, D H ^a   Layland, L E ^d   Prazeres da Costa, C U ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b CAIRO UNIVERSITY   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

^d UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Granzyme B; Helios; Hepatitis C virus; Liver disease; Regulatory T cells; Schistosoma mansoni

Indexed keywords

GRANZYME B; INTERFERON; PEPTIDES AND PROTEINS; PROTEIN HELIOS; UNCLASSIFIED DRUG; INTERLEUKIN 8;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER DISEASE; MALE; MIXED INFECTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SCHISTOSOMIASIS; VIRUS LOAD; VIRUS REPLICATION; ANIMAL; HEPACIVIRUS; IMMUNOLOGY; LIVER; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; VIROLOGY;

HEPATITIS C VIRUS; SCHISTOSOMA; SCHISTOSOMA MANSONI;

ADULT; ANIMALS; COINFECTION; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERLEUKIN-8; LIVER; MALE; MIDDLE AGED; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; T-LYMPHOCYTES, REGULATORY; VIRAL LOAD;

EID: 84921324746     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/pim.12171     Document Type: Article

References (48)

1. Seeff LB. Natural history of hepatitis C. Am J Med 1999; 107: 10S-15S.
2. Ray SC, Arthur RR, Carella A, Bukh J & Thomas DL. Genetic epidemiology of hepatitis C virus throughout egypt. J Infect Dis 2000; 182: 698-707.
3. Frank C, Mohamed MK, Strickland GT, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000; 355: 887-891.
4. Abdel-Aziz F, Habib M, Mohamed MK, et al. Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology 2000; 32: 111-115.
5. Habib M, Mohamed MK, Abdel-Aziz F, et al. Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity. Hepatology 2001; 33: 248-253.
6. Shoukry NH, Cawthon AG & Walker CM. Cell-mediated immunity and the outcome of hepatitis C virus infection. Annu Rev Microbiol 2004; 58: 391-424.
7. Billerbeck E, Bottler T & Thimme R. Regulatory T cells in viral hepatitis. World J Gastroenterol 2007; 13: 4858-4864.
8. Boettler T, Spangenberg HC, Neumann-Haefelin C, et al. T cells with a CD4+ CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 2005; 79: 7860-7867.
9. Strickland GT. Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors. Hepatology 2006; 43: 915-922.
10. Angelico M, Renganathan E, Gandin C, et al. Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections. J Hepatol 1997; 26: 236-243.
11. Strickland GT, Elhefni H, Salman T, et al. Role of hepatitis C infection in chronic liver disease in Egypt. Am J Trop Med Hyg 2002; 67: 436-442.
12. Kamal S, Madwar M, Bianchi L, et al. Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni. Liver 2000; 20: 281-289.
13. Kamal SM, Rasenack JW, Bianchi L, et al. Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response. Gastroenterology 2001; 121: 646-656.
14. Kamal SM, Madwar MA, Peters T, Fawzy R & Rasenack J. Interferon therapy in patients with chronic hepatitis C and schistosomiasis. J Hepatol 2000; 32: 172-174.
15. Chitsulo L, Engels D, Montresor A & Savioli L. The global status of schistosomiasis and its control. Acta Trop 2000; 77: 41-51.
16. Pearce EJ & MacDonald AS. The immunobiology of schistosomiasis. Nat Rev Immunol 2002; 2: 499-511.
17. Doenhoff MJ, Hagan P, Cioli D, et al. Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs. Parasitology 2009; 136: 1825-1835.
18. El-Khoby T, Galal N, Fenwick A, et al. The epidemiology of schistosomiasis in Egypt: summary findings in nine governorates. Am J Trop Med Hyg 2000; 62: 88-99.
19. King CL, Medhat A, Malhotra I, et al. Cytokine control of parasite-specific anergy in human urinary schistosomiasis. IL-10 modulates lymphocyte reactivity. J Immunol 1996; 156: 4715-4721.
20. Malaquias LC, Falcao PL, Silveira AM, et al. Cytokine regulation of human immune response to Schistosoma mansoni: analysis of the role of IL-4, IL-5 and IL-10 on peripheral blood mononuclear cell responses. Scand J Immunol 1997; 46: 393-398.
21. van der Kleij D, Latz E, Brouwers JF, et al. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J Biol Chem 2002; 277: 48122-48129.
22. Layland LE, Wagner H & da Costa CU. Lack of antigen-specific Th1 response alters granuloma formation and composition in Schistosoma mansoni-infected MyD88-/- mice. Eur J Immunol 2005; 35: 3248-3257.
23. McKee AS & Pearce EJ. CD25+ CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development. J Immunol 2004; 173: 1224-1231.
24. Layland LE, Rad R, Wagner H & da Costa CU. Immunopathology in schistosomiasis is controlled by antigen-specific regulatory T cells primed in the presence of TLR2. Eur J Immunol 2007; 37: 2174-2184.
25. Layland LE, Mages J, Loddenkemper C, et al. Pronounced phenotype in activated regulatory T cells during a chronic helminth infection. J Immunol 2010; 184: 713-724.
26. Bolacchi F, Sinistro A, Ciaprini C, et al. Increased hepatitis C virus (HCV)-specific CD4+ CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels. Clin Exp Immunol 2006; 144: 188-196.
27. Bruns T, Steinmetzer K, Ermantraut E & Stallmach A. Hepatitis C virus RNA quantitation in venous and capillary small-volume whole-blood samples. J Clin Microbiol 2009; 47: 3231-3240.
28. Golden-Mason L, Burton JR Jr, Castelblanco N, et al. Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence. Hepatology 2006; 44: 1098-1109.
29. Dunham RM, Cervasi B, Brenchley JM, et al. CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection. J Immunol 2008; 180: 5582-5592.
30. Paiardini M, Cervasi B, Albrecht H, et al. Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals. J Immunol 2005; 174: 2900-2909.
31. Layland LE, Mages J, Loddenkemper C, et al. Pronounced phenotype in activated regulatory T cells during a chronic helminth infection. J Immunol 2010; 184: 713-724.
32. Thornton AM, Korty PE, Tran DQ, et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol 2010; 184: 3433-3441.
33. Hesse M, Piccirillo CA, Belkaid Y, et al. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol 2004; 172: 3157-3166.
34. Chieffi PP. Interrelationship between schistosomiasis and concomitant diseases. Mem Inst Oswaldo Cruz 1992; 87(Suppl 4): 291-296.
35. Osada Y & Kanazawa T. Schistosome: Its benefit and harm in patients suffering from concomitant diseases. J Biomed Biotechnol 2011; 2011: 10.
36. Post J, Ratnarajah S & Lloyd AR. Immunological determinants of the outcomes from primary hepatitis C infection. Cell Mol Life Sci 2009; 66: 733-756.
37. Spengler U & Nattermann J. Immunopathogenesis in hepatitis C virus cirrhosis. Clin Sci (Lond) 2007; 112: 141-155.
38. Langhans B, Braunschweiger I, Arndt S, et al. Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C. Clin Sci (Lond) 2010; 119: 97-109.
39. Ward SM, Fox BC, Brown PJ, et al. Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection. J Hepatol 2007; 47: 316-324.
40. Wammes LJ, Hamid F, Wiria AE, et al. Regulatory T cells in human geohelminth infection suppress immune responses to BCG and Plasmodium falciparum. Eur J Immunol 2010; 40: 437-442.
41. Watanabe K, Mwinzi PN, Black CL, et al. T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatment. Am J Trop Med Hyg 2007; 77: 676-682.
42. Teixeira-Carvalho A, Martins-Filho OA, Peruhype-Magalhaes V, et al. Cytokines, chemokine receptors, CD4+ CD25HIGH+ T-cells and clinical forms of human schistosomiasis. Acta Trop 2008; 108: 139-149.
43. Akimova T, Beier UH, Wang L, Levine MH & Hancock WW. Helios expression is a marker of T cell activation and proliferation. PLoS ONE 2011; 6: e24226.
44. Gottschalk RA, Corse E & Allison JP. Expression of Helios in peripherally induced Foxp3+ regulatory T cells. J Immunol 2012; 188: 976-980.
45. Specht S & Hoerauf A. Does helminth elimination promote or prevent malaria? Lancet 2007; 369: 446-447.
46. Borkow G & Bentwich Z. Chronic parasite infections cause immune changes that could affect successful vaccination. Trends Parasitol 2008; 24: 243-245.
47. Cooper PJ, Chico M, Sandoval C, et al. Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR. Infect Immun 2001; 69: 1574-1580.
48. Farid A, Al-Sherbiny M, Osman A, et al. Schistosoma infection inhibits cellular immune responses to core HCV peptides. Parasite Immunol 2005; 27: 189-196.